ArticleScientific reports2021

Optimizing proton minibeam radiotherapy by interlacing and heterogeneous tumor dose on the basis of calculated clonogenic cell survival.

Matthias Sammer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.